JP2021191771A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021191771A5 JP2021191771A5 JP2021140167A JP2021140167A JP2021191771A5 JP 2021191771 A5 JP2021191771 A5 JP 2021191771A5 JP 2021140167 A JP2021140167 A JP 2021140167A JP 2021140167 A JP2021140167 A JP 2021140167A JP 2021191771 A5 JP2021191771 A5 JP 2021191771A5
- Authority
- JP
- Japan
- Prior art keywords
- mesenchymal stem
- stem cells
- pharmaceutical preparation
- cells
- usage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023023996A JP2023065486A (ja) | 2004-03-22 | 2023-02-20 | 間葉幹細胞及びその使用法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55511804P | 2004-03-22 | 2004-03-22 | |
| US60/555,118 | 2004-03-22 | ||
| JP2020047240A JP7033159B2 (ja) | 2004-03-22 | 2020-03-18 | 間葉幹細胞及びその使用法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020047240A Division JP7033159B2 (ja) | 2004-03-22 | 2020-03-18 | 間葉幹細胞及びその使用法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023023996A Division JP2023065486A (ja) | 2004-03-22 | 2023-02-20 | 間葉幹細胞及びその使用法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021191771A JP2021191771A (ja) | 2021-12-16 |
| JP2021191771A5 true JP2021191771A5 (https=) | 2022-04-22 |
| JP7546239B2 JP7546239B2 (ja) | 2024-09-06 |
Family
ID=46060822
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012058539A Expired - Lifetime JP6114500B2 (ja) | 2004-03-22 | 2012-03-15 | 間葉幹細胞及びその使用法 |
| JP2014241859A Expired - Lifetime JP5997237B2 (ja) | 2004-03-22 | 2014-11-28 | 間葉幹細胞及びその使用法 |
| JP2017003854A Expired - Lifetime JP6382360B2 (ja) | 2004-03-22 | 2017-01-13 | 間葉幹細胞及びその使用法 |
| JP2017155229A Expired - Lifetime JP6757300B2 (ja) | 2004-03-22 | 2017-08-10 | 間葉幹細胞及びその使用法 |
| JP2018190636A Expired - Lifetime JP6757383B2 (ja) | 2004-03-22 | 2018-10-09 | 間葉幹細胞及びその使用法 |
| JP2020047240A Expired - Lifetime JP7033159B2 (ja) | 2004-03-22 | 2020-03-18 | 間葉幹細胞及びその使用法 |
| JP2021140167A Expired - Lifetime JP7546239B2 (ja) | 2004-03-22 | 2021-08-30 | 間葉幹細胞及びその使用法 |
| JP2023023996A Pending JP2023065486A (ja) | 2004-03-22 | 2023-02-20 | 間葉幹細胞及びその使用法 |
Family Applications Before (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012058539A Expired - Lifetime JP6114500B2 (ja) | 2004-03-22 | 2012-03-15 | 間葉幹細胞及びその使用法 |
| JP2014241859A Expired - Lifetime JP5997237B2 (ja) | 2004-03-22 | 2014-11-28 | 間葉幹細胞及びその使用法 |
| JP2017003854A Expired - Lifetime JP6382360B2 (ja) | 2004-03-22 | 2017-01-13 | 間葉幹細胞及びその使用法 |
| JP2017155229A Expired - Lifetime JP6757300B2 (ja) | 2004-03-22 | 2017-08-10 | 間葉幹細胞及びその使用法 |
| JP2018190636A Expired - Lifetime JP6757383B2 (ja) | 2004-03-22 | 2018-10-09 | 間葉幹細胞及びその使用法 |
| JP2020047240A Expired - Lifetime JP7033159B2 (ja) | 2004-03-22 | 2020-03-18 | 間葉幹細胞及びその使用法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023023996A Pending JP2023065486A (ja) | 2004-03-22 | 2023-02-20 | 間葉幹細胞及びその使用法 |
Country Status (5)
| Country | Link |
|---|---|
| JP (8) | JP6114500B2 (https=) |
| AT (1) | ATE556134T1 (https=) |
| CA (3) | CA2868733C (https=) |
| ES (7) | ES2657382T5 (https=) |
| TR (1) | TR201901268T4 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2298864B1 (en) * | 2004-03-22 | 2017-10-11 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
| ATE556134T1 (de) * | 2004-03-22 | 2012-05-15 | Osiris Therapeutics Inc | Mesenchymstammzellen und verwendungendafür |
| EP2849765A4 (en) * | 2012-05-16 | 2015-12-02 | Univ Johns Hopkins | STEM CELLS AS INDIVIDUALIZED MATERNAL THERAPY FOR THE PREVENTION OF EARLY BIRTHS |
| JP2016210730A (ja) * | 2015-05-08 | 2016-12-15 | 上田 実 | 医薬組成物及びその製造方法並びに医薬品 |
| WO2018092769A1 (ja) | 2016-11-15 | 2018-05-24 | 株式会社カネカ | 胎児付属物に由来する間葉系幹細胞を含む細胞集団とその製造方法、及び医薬組成物 |
| CN119033819A (zh) | 2017-11-22 | 2024-11-29 | 迈索布拉斯特国际有限公司 | 细胞组合物及治疗方法 |
| WO2019132026A1 (ja) | 2017-12-28 | 2019-07-04 | 株式会社カネカ | 接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物 |
| WO2020251020A1 (ja) | 2019-06-14 | 2020-12-17 | 株式会社カネカ | 間葉系細胞を含む細胞集団、それを含む医薬組成物、及び、その製造方法 |
| AU2020330745A1 (en) * | 2019-08-15 | 2022-03-24 | Nextcell Pharma Ab | Allogeneic composition for treatment of CNS disorders |
| CN113813288B (zh) * | 2021-08-11 | 2024-02-13 | 谢岩 | 间充质干细胞及包含其的组合物用于制备治疗烧伤难愈创面的药物的用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0651641B2 (ja) * | 1983-08-29 | 1994-07-06 | 株式会社ミドリ十字 | ガンマ・インターフェロン組成物 |
| JPH01501792A (ja) * | 1986-03-17 | 1989-06-22 | シェリング・コーポレーション | γ型インターフェロンによる癌の治療 |
| CA2191733A1 (en) * | 1994-06-07 | 1995-12-21 | Daniel A. Vallera | Methods for inhibiting antigen specific t cell responses |
| AU2808397A (en) * | 1996-04-26 | 1997-11-19 | Case Western Reserve University | Skin regeneration using mesenchymal stem cells |
| US6368636B1 (en) * | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| AU755888B2 (en) * | 1998-03-18 | 2003-01-02 | Mesoblast International Sarl | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| AU2999199A (en) | 1998-04-03 | 1999-10-25 | Osiris Therapeutics, Inc. | Mesenchymal stem cells as immunosuppressants |
| CN1307303C (zh) * | 2000-01-19 | 2007-03-28 | 帕卡什·S·吉尔 | 针对反义vegf寡核苷酸的方法和组合物 |
| DE60143517D1 (de) * | 2000-04-25 | 2011-01-05 | Osiris Therapeutics Inc | Wiederherstellung der gelenken mit mesenchymalen stammzellen |
| DK2311869T3 (da) * | 2002-02-01 | 2013-03-18 | Merck Sharp & Dohme | Anvendelse af pattedyrcytokinrelaterede reagenser |
| JP3897343B2 (ja) * | 2002-08-01 | 2007-03-22 | 株式会社林原生物化学研究所 | 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質 |
| WO2004052177A2 (en) * | 2002-12-05 | 2004-06-24 | Case Western Reserve University | Cell-based therapies for ischemia |
| EP2298864B1 (en) * | 2004-03-22 | 2017-10-11 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
| ATE556134T1 (de) * | 2004-03-22 | 2012-05-15 | Osiris Therapeutics Inc | Mesenchymstammzellen und verwendungendafür |
-
2005
- 2005-03-15 AT AT05725577T patent/ATE556134T1/de active
- 2005-03-15 ES ES14172807T patent/ES2657382T5/es not_active Expired - Lifetime
- 2005-03-15 ES ES10011226.7T patent/ES2645018T3/es not_active Expired - Lifetime
- 2005-03-15 ES ES05725577T patent/ES2385450T3/es not_active Expired - Lifetime
- 2005-03-15 ES ES10011223.4T patent/ES2643030T3/es not_active Expired - Lifetime
- 2005-03-15 CA CA2868733A patent/CA2868733C/en not_active Expired - Lifetime
- 2005-03-15 TR TR2019/01268T patent/TR201901268T4/tr unknown
- 2005-03-15 ES ES10011225.9T patent/ES2544689T3/es not_active Expired - Lifetime
- 2005-03-15 CA CA2934682A patent/CA2934682C/en not_active Expired - Lifetime
- 2005-03-15 CA CA3135582A patent/CA3135582A1/en active Pending
- 2005-03-15 ES ES10011224.2T patent/ES2643076T3/es not_active Expired - Lifetime
- 2005-03-15 ES ES14172800T patent/ES2708627T3/es not_active Expired - Lifetime
-
2012
- 2012-03-15 JP JP2012058539A patent/JP6114500B2/ja not_active Expired - Lifetime
-
2014
- 2014-11-28 JP JP2014241859A patent/JP5997237B2/ja not_active Expired - Lifetime
-
2017
- 2017-01-13 JP JP2017003854A patent/JP6382360B2/ja not_active Expired - Lifetime
- 2017-08-10 JP JP2017155229A patent/JP6757300B2/ja not_active Expired - Lifetime
-
2018
- 2018-10-09 JP JP2018190636A patent/JP6757383B2/ja not_active Expired - Lifetime
-
2020
- 2020-03-18 JP JP2020047240A patent/JP7033159B2/ja not_active Expired - Lifetime
-
2021
- 2021-08-30 JP JP2021140167A patent/JP7546239B2/ja not_active Expired - Lifetime
-
2023
- 2023-02-20 JP JP2023023996A patent/JP2023065486A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021191771A5 (https=) | ||
| Gonzalez-Rothi et al. | Intermittent hypoxia and neurorehabilitation | |
| KR20150059132A (ko) | 비관절염 포유동물의 운동으로 유발된 관절 통증을 감소시키는 방법 | |
| JP5797268B2 (ja) | 抗疲労組成物、その製剤及び応用 | |
| JP2018522919A (ja) | プロピオニバクテリウム・アクネス(Propionibacterium acnes)による感染症、特にざ瘡の処置に使用するための乳酸菌の組成物 | |
| KR20100000922A (ko) | 정제 마유를 유효성분으로 함유하는 아토피성 피부염 치료또는 예방용 조성물 | |
| TW201642890A (zh) | 以青黛或產靛藍植物提取物治療異位性皮膚炎 | |
| EP3463291A1 (en) | Bacteria-based gel compositions for topical applications and uses thereof | |
| CN106266384A (zh) | 一种防治婴儿尿布疹的植物药膏及其制备方法 | |
| AR047005A1 (es) | Cuerpos de inclusion que transportan glicerol-fosfato aceptables para uso farmaceutico | |
| JP6778200B2 (ja) | Spiranthes sinensis抽出物を含有する組成物およびその薬学的適用 | |
| TWI277421B (en) | Use of a mare's milk concentrate dried on a biologically inert, highly-disperse matrix | |
| Halim et al. | A comparison study on the effectiveness of local honey and salicylate gel for treatment of minor recurrent aphtous stomatitis | |
| KR20260030114A (ko) | 신규한 다기능성 올리고펩타이드 | |
| TW202421177A (zh) | 疲勞感、睡眠障礙或眼睛疲勞及更年期症狀改善用組成物 | |
| Ranzenigo et al. | HIV cure-related research: where we stand and where we go | |
| CN102697855B (zh) | 治疗皮肤疾病的药物组合物 | |
| WO2016120647A4 (en) | Muscle regeneration | |
| EP4153196A2 (en) | Shelf- stable ammonia oxidizing microorganism preparations | |
| JP3652865B2 (ja) | 乳酸縮合物の混合物及びそれを含有する組成物 | |
| Chandra et al. | Progresses in wound healing: integrating nutrition, physical therapy, traditional and alternative medicine, and novel technologies | |
| Murthy et al. | Formulation and Evaluation of Medicated Derma Sticks of Ficus Racemosa for Management of Infectious Skin Diseases | |
| RU2302854C1 (ru) | Средство для массажа | |
| Tomaszewski et al. | The analysis and assessment of the effect of selected endo-and exogenous substances on prevention and treatment of selected conditions and injuries within the musculoskeletal system | |
| Chou et al. | 1116 Novel androgen receptor degrader for androgenetic alopecia (AGA) application |